Cargando…
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
Replication‐incompetent adenovirus (Ad) vector and mRNA‐lipid nanoparticle (LNP) constructs represent two modular vaccine platforms that have attracted substantial interest over the past two decades. Due to the COVID‐19 pandemic and the rapid development of multiple successful vaccines based on thes...
Autores principales: | Provine, Nicholas M., Klenerman, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877955/ https://www.ncbi.nlm.nih.gov/pubmed/36330560 http://dx.doi.org/10.1002/eji.202250022 |
Ejemplares similares
-
Variant constraint by mRNA vaccines
por: Bordon, Yvonne
Publicado: (2021) -
Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022) -
mRNA vaccine shows promise in autoimmunity
por: Flemming, Alexandra
Publicado: (2021) -
Coronavirus Variants—Will New mRNA Vaccines Meet the Challenge?
por: Welsh, Jennifer
Publicado: (2021) -
Puzzling mRNA: Alternative splicing fine-tunes specificity and function
por: Häfner, Sophia Julia
Publicado: (2019)